SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- Under 14 years old dies after being hit by a train in San Nicolás Nov 24, 2022
- Sociosphere, the new portal for online consultancy from the best influencers Jul 9, 2021
- Is American Express raising premium card fees too soon? Jul 1, 2021
- Insiders called the timing of the release of the iPhone 12 Jul 30, 2020
- Altercation Hanouna – Boyard: What risks the presenter of “TPMP” after the complaint of deputy Nupes? Nov 15, 2022
- World Cup 2022: “20 Minutes” verified several claims about the rules in force in Qatar Nov 23, 2022
- Avis appeal: “Important to donate blood now. Transfusions in sharp decline “ Jul 30, 2021